SK
Sumit Kumar Pandey
About Sumit Kumar Pandey
Data last updated:
Sumit Kumar Pandey is a Director at Dhanlaxmi Healtcare Private Limited (since 2021) and Director at Norbix Pharma Private Limited (since 2024). The companies operate in Pharma. The largest current company by reported revenue is Dhanlaxmi Healtcare Private Limited at ₹5.46 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 20 Mar 2021 | 2021 | ₹5.46 Cr (FY 2025) | Active | |
| Director | 15 Jan 2024 | 2023 | Active |
Board colleagues of Sumit Kumar Pandey
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dilip Pandey | 09116503 | Dhanlaxmi Healtcare Private Limited | Director |
| Usha Sharma | 10546123 | Dhanlaxmi Healtcare Private Limited | Director |
| Ankit Raj | 10265451 | Norbix Pharma Private Limited | Director |
| Gurpreet Singh | 10475870 | Norbix Pharma Private Limited | Director |
| Sunil Malik | 08964315 | Norbix Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sumit Kumar Pandey
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sumit Kumar Pandey
Sumit Kumar Pandey currently holds 2 directorships: Dhanlaxmi Healtcare Private Limited (Director, since 20 Mar 2021, revenue ₹5.46 Cr (FY 2025)); Norbix Pharma Private Limited (Director, since 15 Jan 2024).
Sumit Kumar Pandey was first appointed on 20 Mar 2021 as Director at Dhanlaxmi Healtcare Private Limited. The most recent appointment on record is 15 Jan 2024 at Norbix Pharma Private Limited.
The current boards of Sumit Kumar Pandey's companies include Dilip Pandey (Dhanlaxmi Healtcare Private Limited), Usha Sharma (Dhanlaxmi Healtcare Private Limited), Ankit Raj (Norbix Pharma Private Limited), Gurpreet Singh (Norbix Pharma Private Limited), Sunil Malik (Norbix Pharma Private Limited).